Research programme: antibody-drug conjugates - BioMed Valley DiscoveriesAlternative Names: BVD CD276 ADC; BVD TEM8 ADC
Latest Information Update: 25 Feb 2016
At a glance
- Originator BioMed Valley Discoveries
- Class Drug conjugates; Immunoconjugates
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 25 Feb 2016 Preclinical trials in Cancer in USA (unspecified route) before February 2016